Health ❯Healthcare ❯Diabetes

Type 2 Diabetes

Treatment Options GLP-1 Receptor Agonists Semaglutide Prediabetes Medications Blood Sugar Control Blood Sugar Management Tirzepatide Medication Insulin Efsitora Alfa

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Amgen plans to use lower starting doses with gradual escalation to improve tolerability ahead of expanded Phase 3 studies

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

Weight-Loss Injections Linked to Increased Fertility and 'Ozempic Babies'

Diabetes and Obesity Drugs Found to Protect Kidney Health

Doctors Question Safety and Efficacy of GLP-1 Supplements and Drugs for Weight Loss

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations

Weekly Insulin Shots Match Daily Injections in Diabetes Management

Eli Lilly's Tirzepatide Shows 94% Reduction in Diabetes Risk

NHS 'Soup and Shake' Diet Shows Promise in Reversing Type 2 Diabetes

Semaglutide Drugs Show Potential Beyond Weight Loss